Update on Cardiac Tumors – review (RCD code: VI)
Journal Title: Journal of Rare Cardiovascular Diseases - Year 2014, Vol 1, Issue 8
Abstract
The prevalence of cardiac tumors is 0.021% (1 person in 5000). These data are based on a meta-analysis of pathological studies from the early decades of the twentieth century. It is likely that nowadays the incidence of cardiac tumors and primary tumors of the heart is greater. The cardiac tumors are very rare and histologically heterogeneous. These leads to, the lack of established diagnostic schemes, that would allow to distinguish cardiac tumors from metastatic tumors, intracardiac thrombus, vegetations on the valves in infective endocarditis or in the process of connective tissue diseases or thrombotic changes of the valves in the process of metastatic disease (called endocarditis marantica). Cardiac tumors may be symptomatic or found incidentally during evaluation for a seemingly unrelated problem or physical finding. In symptomatic patients, a mass can virtually always be detected by echocardiography, magnetic resonance imaging (MRI), and/or computed tomography (CT). Because symptoms may mimic other cardiac conditions, the clinical challenge is to consider the possibility of a cardiac tumor so that the appropriate diagnostic tests can be conducted. There are very few studies, assessing the results of cardiac surgery in the individual centers. There is also lack of set of standards in the chemotherapy of malignant cardiac tumors. Moreover its routine use is sometimes discussed. JRCD 2014; 1 (8): 5–10
Authors and Affiliations
Monika Komar, Giovanni La Canna, Ula Gancarczyk, Paweł Prochownik, Hanna Dziedzic‑Oleksy, Piotr Podolec
Keywords
Related Articles
- EP ID EP245410
- DOI 10.20418/jrcd.vol1no8.158
- Views 86
- Downloads 0
Safety of pulmonary vein isolation in atrial fibrillation patients treated with dabigatran when idarucizumab is available
Patients with atrial fibrillation (AF) are at increased risk of stroke and systemic thromboembolism and prevention of such episodes is ensured by choosing appropriate anticoagulation. In paroxysmal drug‐refractory AF, ca...
Highlights from EuroEcho-Imaging 2016 Congress of the European Society of Cardiology, Leipzig, Germany.
EuroEcho-Imaging is the annual meeting of the European Association of Cardiovascular Imaging (EACVI), that attracts participants from all over the world with all modalities of cardiovascular non-invasive imaging. This ti...
Partial anomalous pulmonary venous connection (RCD code: II-3C.0)
A 48-year-old woman was admitted to our institution with a year’s history of uncharacteristic chest pain episodes and decrease in exercise tolerance. A CT lung scan performed nine months earlier revealed an anomalous vei...
Pulmonary arterial hypertension in a patient with unilateral pulmonary artery absence (RCD code: II-2A.1)
Pulmonary artery absence is a rare congenital defect, occurring in 1 out of 100 000 individuals. In its isolated unilateral form only one in three cases concerns the left artery. The first symptoms usually appear in youn...
3rd Symposium on Rare Cardiovascular Diseases – ESC Amsterdam 2013: Chairperson’s Perspective
The 3rd Satellite Symposiumon Rare Cardiovascular Diseases, which was organized by the Krakow Center for Rare Cardiovascular Diseases, was officially included in the Program of the 2013 ESC Congress and was held in the E...